Integra LifeSciences Holdings Corp. (IART)

13.04 +0.04 (+0.31%) USD  |  NASDAQ  |  Dec 17, 16:00
13.04 0.00 (0.00%) After-Hours: 18:23
More

Integra LifeSciences Holdings Research and Development Expense (Annual): 54.43M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for IART.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Masimo Corp. 222.80M
LeMaitre Vascular, Inc. 15.65M
Clearpoint Neuro, Inc. 12.39M
Tandem Diabetes Care, Inc. 184.17M
iRhythm Technologies, Inc. 71.46M